Skip to main content

Table 3 Lymphocyte and immunoglobulin of this patient during the COVID-19 pandemic

From: Case report: novel NFKB2 variant associated with pediatric eosinophilic granulomatosis with polyangiitis (EGPA) in the COVID-19 pandemic

 

Dec 6, 2022

Dec 21, 2022

Jan 8, 2023

Normal range

CD3%

89.60

91.50

91.00

52 ~ 78

CD3 (× 10^9/L)

1.31

1.00

0.23

0.7 ~ 4.2

CD4%

43.30

38.80

28.40

25 ~ 48

CD4 (× 10^9/L)

0.63

0.42

0.07

0.3 ~ 2

CD8%

43.70

51.20

61.20

19 ~ 34

CD8 (× 10^9/L)

0.64

0.56

0.15

0.3 ~ 1.8

CD4/CD8

1.00 ↓

0.80 ↓

0.50 ↓

1.5 ~ 2

CD19%

6.90 ↓

6.90 ↓

6.50 ↓

10 ~ 31

CD19 (× 10^9/L)

0.10

0.08 ↓

0.02 ↓

0.2 ~ 1.6

CD16/56%

2.70

0.90 ↓

1.90 ↓

4 ~ 26

CD16/56 (× 10^9/L)

0.04

0.01

 < 0.01

0.09 ~ 0.9

IgG(g/L)

—

3.30 ↓

—

5.29 ~ 21.9

IgA(g/L)

—

0.07 ↓

—

0.41 ~ 3.95

IgM(g/L)

—

0.68

—

0.48 ~ 2.26

  1. —: Not detected
  2. ↓: Indicates a drop in values